Dosimetry of the I-Plant Model 3500 iodine-125 brachytherapy source

被引:25
|
作者
Duggan, DM [1 ]
Johnson, BL [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN 37232 USA
关键词
dosimetry; I-125; Task Group 43; brachytherapy;
D O I
10.1118/1.1357456
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
I-125 brachytherapy sources have been widely used for interstitial implants for a number of years in several tumor sites, especially the prostate. The design of the new I-Plant Model 3500 iodine source is novel, yet its characteristics are similar to those of two existing designs, Model 6711 and the Symmetra. Dosimetry parameters (including dose rate constant, radial dose function, and anisotropy function, as defined by AAPM Task Group 43) were measured with LiF thermoluminescent dosimeters in water-equivalent plastic phantoms. The dose rate constant was found by direct comparison of calibrated I-Plant Model 3500 and Model 6711 seeds in a solid water phantom, to be 1.01 (cGy/h)/U. The radial dose function and anisotropy function are similar to those of the Model 6711 and Symmetra seeds. (C) 2001 American Association of Physicists in Medicine.
引用
收藏
页码:661 / 670
页数:10
相关论文
共 50 条
  • [21] Surgical resection and permanent iodine-125 brachytherapy for brain metastases
    Kim Huang
    Penny K. Sneed
    Sandeep Kunwar
    Annemarie Kragten
    David A. Larson
    Mitchel S. Berger
    Albert Chan
    Jean Pouliot
    Michael W. Mcdermott
    Journal of Neuro-Oncology, 2009, 91
  • [22] Histopathology of Intraocular Medulloepithelioma following Iodine-125 Plaque Brachytherapy
    Mohan, Sukriti
    Gange, William Steven
    Kim, Jonathan
    Saber, Maria Elena Sibug
    CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (01): : 196 - 203
  • [23] Mass Production of Source Core for Iodine-125 Seed
    Lee, Jin Hee
    Park, Ul Jae
    Son, Kwang Jae
    Choi, Kang Hyuk
    Yu, Kook Hyun
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2014, 35 (07): : 2172 - 2174
  • [24] Deposition of Iodine-125 on Silver Supports of Microsources for Prostate Cancer Brachytherapy
    V. V. Shapovalov
    S. A. Artamonov
    N. V. Eldashev
    A. Yu. Kutin
    N. A. Nerozin
    D. A. Podsoblyaev
    M. D. Samsonov
    N. R. Togaeva
    S. V. Tkachev
    Radiochemistry, 2022, 64 : 641 - 644
  • [25] Iodine-125 Brachytherapy of Brain Stem TumorsJod-125-Brachytherapie von Hirnstammtumoren
    Jenö Julow
    Árpád Viola
    Tibor Major
    István Valálik
    Sarolta Sági
    László Mangel
    Beáta R. Kovács
    Imre Repa
    Gábor Bajzik
    Takácsi N. Zoltán
    György Németh
    Strahlentherapie und Onkologie, 2004, 180 (7) : 449 - 454
  • [26] Deposition of Iodine-125 on Silver Supports of Microsources for Prostate Cancer Brachytherapy
    Shapovalov, V. V.
    Artamonov, S. A.
    Eldashev, N. V.
    Kutin, A. Yu.
    Nerozin, N. A.
    Podsoblyaev, D. A.
    Samsonov, M. D.
    Togaeva, N. R.
    Tkachev, S. V.
    RADIOCHEMISTRY, 2022, 64 (05) : 641 - 644
  • [27] Measurement of the strength of iodine-125 seed moving at unknown speed during implantation in brachytherapy
    Tanaka, Kenichi
    Endo, Satoru
    Tateoka, Kunihiko
    Asanuma, Osamu
    Kamo, Ken-ichi
    Sato, Kaori
    Takeda, Hiromitsu
    Takagi, Masaru
    Hareyama, Masato
    Takada, Jun
    JOURNAL OF RADIATION RESEARCH, 2014, 55 (01) : 162 - 167
  • [28] Brachytherapy for intracranial meningioma using a permanently implanted iodine-125 seed
    Obasi, PC
    Barnett, GH
    Suh, JH
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2002, 79 (01) : 33 - 43
  • [29] Iodine-125 brachytherapy alone for advanced primary parotid gland carcinoma
    Zhou, C.
    Zhang, J.
    Zhang, J. -G.
    Liu, S. -M.
    Zheng, L.
    Huang, M. -W.
    Shi, Y.
    Lv, X. -M.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2018, 47 (05) : 561 - 567
  • [30] TTT as rescue treatment for choroidal melanoma not controlled with iodine-125 brachytherapy
    Robertson, DM
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2002, 10 (04) : 247 - 252